Psi-2 lines are based on NIH 3T3 cells capable of producing all the necessary trans proteins -gag, pol, and env. Those RNA molecules that have in cis the Psi packaging signal are packaged into maturing virions.
Unlike the Gag proteins, the Env polyprotein precursor is transcribed from a spliced, subgenomic mRNA which contains no packaging signals, and is cleaved into the mature SU and TM proteins by the action of a cellular protease.
SU is heavily N-glycosylated protein, responsible for receptor binding at the surface of cells.
TM is usually N-glycosylated, although not heavily. It has a hydrophobic domain which spans the cell and virus envelope. The outer domain of the protein has a relatively hydrophobic N-terminus referred to as the fusion domain thought to contact the cell surface after a SU binding to receptor.
SU proteins are often critical determinants of the pathogenic "virulence" and disease-type specificity of the virus.
Env proteins
Retroviruses enter by at least two different manners, dependent upon the retroviral subclass:
* fusion * facilitated phagocytosis
The viral envelope is critical in each case for recognizing appropriate surface receptors to initiate viral fusion to the host target cells.
Viral entry
The RNA genome in the free retrovirus is arranged as a diploid genome of identical sequence.
The mRNA associates with a tRNA primer (Pro, Trp, Lys) that is bound by complementary base pairing to 18 base pairs just 3' to the U5 region.
The retroviral life cycle begins in the nucleus of an infected cell. At this stage the retroviral genome is a DNA element (8-12 kb) integrated into the DNA of the host cell.
Full-length genomic mRNA is made initiating at the R at the 5' LTR. The free particle can infect new cells by binding to a cell surface receptor.
Infection leads to injection of the virus nucleoprotein core (gag proteins, genomic RNA, and the reverse transcriptase).
Once inside the cell, the reverse transcriptase protein initiates creation of a double-stranded DNA copy of the genome of the virus. Upon completion of reverse transcription, the viral integrase intergate the viral DNA into host DNA.
Retroviruses
Transcription proceeds through the genome and mRNA is polyadenylated and processed using signals in transcribed regions from the 3' LTR at the end of the transcribed R.
The full-length mRNA can be spliced to lead to production of envelope proteins. Unspliced full-length mRNA can give rise to gag-pol proteins. A viral protease cleaves the precursor into multiple subunits with varying functions.
The Env protein is also translated as a precursor which is cleaved by endogenous proteases to yield the mature surface glycoprotein.
Translated proteins assemble a retroviral particle at the cell surface. Full-length genomic unspliced mRNA is bound by gag-derived proteins and incorporated into the budding particle.
Their derivation is easy.
Expression from retroviruses is long-term.
Their integration into the host genome allows for their stable transmission through cell division.
This ensures that in cell types which undergo multiple independent maturation steps, such as hematopoietic cell progression, the retrovirus construct will remain resident and continue to express.
Highly transfectable retrovirus producer lines for the generation of helper free ecotropic and amphotropic retroviruses.
The lines are based on the 293T cell line, a human embryonic kidney line transformed with adenovirus E1a and carrying T antigen.
The lines were created by placing into 293T cells constructs capable of producing gag-pol, and envelope protein for ecotropic and amphotropic viruses.
Phoenix -retroviral vector producer cell line
Retroviral gene transfer is a technique for efficiently introducing stable, heritable genetic material into the genome of any dividing cell type.
Current retroviral gene transfer technology is based on the packaging cell lines and retroviral expression vectors.
To develop a packaging cell line, the viral gag, pol, and env genes -necessary for particle formation and replication -are stably integrated into the genome of the packaging cell line. The separate introduction and integration of the structural genes minimizes the chances of producing replication-competent virus due to recombination events during cell proliferation.
Retroviral expression vectors provide the packaging signal Ψ+, transcription and processing elements, and a target gene. Inserts of up to 6.5 kb can be efficiently packaged. Transfection of the retroviral vector into a packaging cell line produces high-titer, replicationincompetent virus. The viral env gene, expressed by the packaging cell line, encodes the envelope protein, which determines the range of infectivity (tropism) of the packaged virus. Viral envelopes are classified according to the receptors used to enter host cells: * Ecotropic virus can recognize a receptor found on only mouse and rat cells. * Amphotropic virus recognizes a receptor found on a broad range of mammalian cell types. * Dualtropic virus recognizes two different receptors found on a broad range of mammalian cell types. * A pantropic virus can infect both mammalian and non-mammalian cells.
Pantropic virions are pseudo-typed with the envelope glycoprotein from the vesicular stomatitis virus (VSV-G), which mediates viral entry through lipid binding and plasma membrane fusion.
Stable expression of the VSV-G envelope protein is toxic; thus, the packaging cell line only contains the viral gag and pol genes. Virus is produced by transiently cotransfecting a retroviral expression vector and pVSV-G into a pantropic packaging cell line.
Retroviral vector technology VSV-G
Once a packaging cell line is transfected with a retroviral expression vector that contains a packaging signal, the viral genomic transcript containing the target gene and selectable marker are packaged into infectious virus within 48-72 hrs.
Alternatively, you can use antibiotic selection to select cells that stably express the integrated vector. Stable virus-producing cells can be frozen and used in later experiments.
Virus produced by both transient and stable transfections can infect target cells and transmit target genes; however, it cannot replicate within target cells because the viral structural genes are absent.
Retroviral vector technology

Retroviral vectors
Virus production in packaging cell lines
The gag, pol and env genes required for viral production are integrated into the packaging cell genome.
The vector provides the viral packaging signal, commonly denoted Ψ+, a target gene, and drug-resistance marker Transfect an expression vector into a packaging cell line.
After 48-72 hours, collect virus and infect a target cell line.
Alternatively, use antibiotic selection to develop clones that stably produce retrovirus.
Transient and stable virus production
The Retro-X™ Universal Packaging System is a transient packaging system that allows to select the envelope according to the tropism needed.
It includes the GP2-293 cell line, which has the viral gag and pol genes incorporated in its genome. The remaining portion of the packaging function, the viral env gene, must be cotransfected with the retroviral expression vector bearing the gene of interest.
The kit includes vectors that encode: * ecotropic, * amphotropic, * dualtropic * pantropic envelope proteins. This allows to cater the tropism or host range of the virus tothe needs by determining which envelope protein is used.
Virus production in packaging cell lines
The RetroPack PT67 Cell Line is derived from a mouse fibroblast (NIH 3T3) cell line designed for stably producing retrovirus.
RetroPack PT67 cells package virus with a dualtropic envelope, 10A1, that recognizes receptors on mouse, rat, human, hamster, mink, cat, dog, and monkey cells.
Virus produced by these cells can enter target cells via two surface molecules, the amphotropic retrovirus receptor, RAM1 (Pit2), and the GALV (Pit1) receptor.
Two viral receptors means that if one receptor is not abundantly expressed by a given species or cell type, the alternate receptor may still allow viral entry.
RetroPack PT67 Cell Line
The EcoPack2-293 and AmphoPack-293 Packaging Cell Lines are human embryonic kidney, HEK 293-derived cell lines designed for transient or stable production of ecotropic or amphotropic retrovirus.
Virus produced by EcoPack2-293 cells possess an ecotropic envelope (gap70), and thus can infect both mouse and rat cells. Virus produced by AmphoPack-293 cells express an amphotropic envelope (4070A), and thus can infect a broad range of mammalian cell types Retroviral sequence within the cell genome has been minimized, reducing the likelihood that replication-competent virus will be produced through recombination.
EcoPack2-293 and AmphoPack-293Cell Lines
GP2-293 Packaging Cell Line
The Pantropic Retroviral Expression System features GP2-293, a HEK 293-based packaging cell line that stably expresses the viral gag and pol genes.
To produce infectious virus, cotransfect GP2-293 with a retroviral expression vector and pVSV-G, a plasmid that expresses VSV-G from the CMV promoter. The VSV-G envelope must be cotransfected with the vector due to toxicity caused by the fusogenic properties of the VSV-G protein.
This system takes advantage of the envelopes ability to infect non-mammalian cells.
All vectors contain the retroviral packaging signal, Ψ+, which promotes virus production.
With the exception of the expression vectors in the MSCV Retroviral Expression System, all vectors are derived from Moloney murine leukemia virus (MMLV). Each vector contains a different antibiotic resistance marker -neomycin, hygromycin, or puromycin.
The MSCV Vectors contain a specifically designed LTR from the murine stem cell PCMV virus, which differs from the MMLV LTR by several point mutations and a deletion. These changes enhance transcriptional activation and decrease transcriptional suppression in embryonic stem and embryonal carcinoma cells.
As a result, the LTR drives high-level constitutive expression of a target gene in stem cells and other mammalian cell lines Use standard molecular biology techniques to transfer a target gene into an expression vector.
Retroviral Expression Vectors
Purify your plasmid by any standard method. The cDNA or gene fragment must contain an ATG initiation codon.
All sequences placed into a retroviral vector must be compatible with the retroviral life cycle and allow complete transcription of the full-length viral genome. Sequences such as poly-A signals must not be included.
Transfect packaging cells by any standard method.
Aspirate culture medium 8-10 hr after transfection, and add 3 ml of complete medium.
Incubate the culture for an additional 48-72 hr to allow viral titer to increase. The viral titer reaches a maximum~48 hr after transfection and is generally at least 30% of the maximum beyond 72 hr after transfection.
Producing vectors
Plate transfected packaging cells in selection medium 24-36 hr after transfection.
Culture cells for one week with the appropriate antibiotic.
Isolate large, healthy colonies and transfer them to individual plates or wells. Once clones are isolated, withdraw antibiotic from the medium.
Culture the clone, until cell culture reaches the desired culture volume.
Viral supernatants can then be harvested in 24 hr intervals until cells are no longer viable. Discard all cells once the virus has been harvested.
Once viral supernatant has been collected, briefly centrifuge sample to remove cellular debris at 500 x g for 10 min.
Aliquot cleared supernatant into single-use tubes to avoid multiple freeze-thaw cycles. since titers can drop as much as 2-4 fold with each cycle.
Store tubes at -70°C. No cryoprotectant is required.
Selecting Stable Virus-Producing Cell Lines
Plate NIH 3T3 cells one day prior to beginning this procedure.
* Prepare 4 mg/ml polybrene. Polybrene is a polycation that reduces charge repulsion between the virus and the cellular membrane.
Collect virus-containing medium from packaging cells.
Filter medium through a 0.45-µm cellulose acetate or polysulfonic (low protein binding) filter. Do not use a nitrocellulose filter because nitrocellulose binds proteins in the retroviral membrane and destroys the virus.
Prepare six 10-fold serial dilutions.
Infect NIH 3T3 cells by adding 1 ml of the diluted virus medium to the wells. Final polybrene concentration will be 4 µg/ml. Subject cells to antibiotic selection 24 hr after infection for one week.
The viral titer corresponds to the number of colonies present at the highest dilution that contains colonies, multiplied by the dilution factor. For example, the presence of 4 colonies in the 10 6 dilution would represent a viral titer of 4 x 10 6 .
For virus produced from RetroPack PT67, EcoPack2-293, AmphoPack-293, and GP2-293 cells, a good viral titer is >10 6 cfu/ml.
Determining Viral Titer
MOI = No. of virus particles per target cell
MMLV does not naturally infect human cells; however, viruses packaged from the MMLVbased vectors described are capable of infecting human cells if packaged in a cell line with the proper tropism. The viral supernatants produced by these retroviral systems could, depending on retroviral insert, contain potentially hazardous recombinant virus.
The user is strongly advised not to create retroviruses capable of expressing known oncogenes in amphotropic, dualtropic or pantropic packaging cell lines.
In the United States, NIH guidelines require that retroviral production and transduction be performed in a Biosafety Level 2 (BL2) facility.
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